UMC Utrecht and VectorY collaborate to identify biomarkers of ALS
The progressive neurological disorder currently affects more than 200,000 people worldwide
Read More
Tag: TDP-43
Study reveals motor neuron region is affected in ALS
The neurological condition currently affects one in 300 people in the UK
Read More
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
